Our newly acquired facility is located in Hillerød, Denmark brings together a complete range of expertise, capabilities and technologies to reliably manufacture advanced biologics. Our large-scale manufacturing facility manufactures innovative therapies and biosimilars for clinical and commercial use. Our medical device assembly, labeling and packing prepares medicines for delivery to more than 90 countries. The campus is the single-largest foreign greenfield investment in Denmark.
Leveraging our manufacturing excellence, we have gained a deep understanding of what it takes to consistently manufacture advanced biologics. Our manufacturing facility has a capacity of 90,000 liters to produce originator molecules and biosimilars of advanced biologics. Our facility for assembly, labeling and packaging manufactures advanced delivery systems and ensures required labeling and secure packaging of the therapies for patients worldwide.
The Hillerød campus also houses quality control laboratories, warehouses, and a number of organizations, supporting the manufacturing activities: planning and purchasing, engineering, and quality assurance.